Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Bangladesh
· Delayed Price · Currency is BDT 9.00
-0.10 (-1.10%)
At close: Nov 14, 2024
IBP Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 13, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2015 |
| Market Capitalization | 1,046 | 1,975 | 2,036 | 2,186 | 2,230 | 2,404 | Upgrade
|
| Market Cap Growth | -2.94% | -2.97% | -6.88% | -1.96% | -7.21% | - | Upgrade
|
| Enterprise Value | 1,070 | 2,047 | 2,079 | 2,262 | 2,167 | 2,157 | Upgrade
|
| Last Close Price | 9.00 | 17.00 | 17.79 | 18.72 | 18.65 | 19.89 | Upgrade
|
| PE Ratio | - | 234.98 | 82.14 | 15.81 | 13.57 | 12.85 | Upgrade
|
| PS Ratio | 4.74 | 5.28 | 4.20 | 2.80 | 2.57 | 3.24 | Upgrade
|
| PB Ratio | 0.65 | 1.22 | 1.25 | 1.35 | 1.47 | 1.75 | Upgrade
|
| P/TBV Ratio | 1.19 | 1.22 | 1.25 | 1.35 | 1.47 | 1.75 | Upgrade
|
| P/FCF Ratio | 13.96 | 46.03 | 42.77 | - | - | - | Upgrade
|
| P/OCF Ratio | 21.69 | 27.08 | 23.32 | 14.48 | 12.71 | 14.41 | Upgrade
|
| EV/Sales Ratio | 5.06 | 5.46 | 4.29 | 2.89 | 2.50 | 2.91 | Upgrade
|
| EV/EBITDA Ratio | 30.22 | 30.52 | 27.74 | 10.81 | 9.00 | 11.28 | Upgrade
|
| EV/EBIT Ratio | - | 71.35 | 58.07 | 13.05 | 10.23 | 12.74 | Upgrade
|
| EV/FCF Ratio | 14.29 | 47.69 | 43.67 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.05 | 0.05 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.99 | 0.65 | 1.01 | 0.41 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.47 | 1.02 | 1.58 | - | - | - | Upgrade
|
| Asset Turnover | 0.11 | 0.20 | 0.26 | 0.43 | 0.52 | 0.53 | Upgrade
|
| Inventory Turnover | 0.94 | 1.55 | 1.76 | 2.39 | 2.65 | 2.40 | Upgrade
|
| Quick Ratio | 2.07 | 1.88 | 1.61 | 1.65 | 1.89 | 2.36 | Upgrade
|
| Current Ratio | 4.67 | 4.26 | 3.49 | 3.57 | 4.82 | 5.31 | Upgrade
|
| Return on Equity (ROE) | -1.12% | 0.52% | 1.55% | 8.57% | 10.80% | 12.88% | Upgrade
|
| Return on Assets (ROA) | -0.08% | 0.95% | 1.18% | 5.95% | 7.96% | 7.54% | Upgrade
|
| Return on Capital (ROIC) | -0.09% | 1.07% | 1.31% | 6.71% | 9.15% | 8.78% | Upgrade
|
| Earnings Yield | -1.80% | 0.43% | 1.24% | 6.16% | 7.01% | 6.46% | Upgrade
|
| FCF Yield | 7.16% | 2.17% | 2.34% | -2.26% | -5.98% | -0.63% | Upgrade
|
| Dividend Yield | 0.00% | - | 0.56% | 2.14% | - | 0.99% | Upgrade
|
| Payout Ratio | 0.00% | 123.72% | 98.46% | 19.97% | 8.49% | - | Upgrade
|
| Buyback Yield / Dilution | 5.98% | - | -2.17% | - | -13.37% | -9.64% | Upgrade
|
| Total Shareholder Return | 5.98% | - | -1.61% | 2.14% | -13.37% | -8.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.